New Milestone in Pakistan’s Immunisation Programme
Rawalpindi’s District Health Authority (DHA) has announced a significant expansion of the country’s national immunisation programme. Cervical cancer has been added as the thirteenth disease targeted by the campaign, joining 12 other life-threatening childhood illnesses. Starting in February 2026, the HPV (human papillomavirus) vaccine will be administered exclusively to nine-year-old girls as part of a year-round, expanded vaccination drive coordinated by local health authorities.
What Changes Are Being Implemented?
From February 2026 onward, the HPV vaccination effort will focus solely on nine-year-old girls. This strategic shift aims to deliver early, long-lasting protection against cervical cancer, one of the deadliest forms of cancer affecting women worldwide. By targeting preadolescents, health officials hope to build immunity before potential exposure to the virus.
Expanded Campaign and Target Diseases
The DHA notes that the expanded campaign now covers 13 diseases, including:
- Tuberculosis
- Diphtheria
- Measles
- Pertussis
- Tetanus
- Polio
- Pneumonia
- Diarrhoea
- Typhoid
- Hepatitis B
- Other longstanding vaccination targets
Officials emphasize that the addition of cervical cancer to the immunisation slate reflects a broader global push to reduce death rates from HPV-related diseases. The nine-year-old target aligns with international best practices designed to maximize vaccine efficacy and long-term protection.
Past Campaign and Achievements
During a recent vaccination drive from September 15 to 27 of this year, health workers reached nine- to fourteen-year-old girls, achieving 94 percent of the set target. Although the forthcoming rollout will narrow the age window, officials say the momentum and lessons from the previous drive will inform smoother execution in February 2026 and beyond.
Officials’ Perspective
DHA CEO Dr Ehsan Ghani told The Express Tribune that the expanded, year-round campaign will begin in February 2026 and continue through the year. He stressed that the decision to vaccinate nine-year-olds against cervical cancer is intended to provide early and lasting protection, reducing the lifetime risk of HPV infection and related cancers.
Why This Move Matters
Cervical cancer remains a major health concern for women around the world, with high mortality rates in many regions. By integrating the HPV vaccine into a national immunisation framework and focusing on preadolescents, Pakistan is taking a proactive stance to curb the disease’s impact. The strategy also reinforces the importance of comprehensive immunisation as a public health tool to prevent preventable illnesses and protect long-term community health.
What This Means for Families
For families in Rawalpindi and surrounding areas, the February rollout will require coordination with local health facilities. Parents and guardians should stay informed about vaccination schedules, eligibility criteria, and the locations where the HPV vaccine will be offered. Health authorities are expected to publish official guidance with practical details as the launch date approaches.
Looking Ahead
As Rawalpindi prepares for the February 2026 start, the HPV vaccine rollout is a landmark step in Pakistan’s public health journey. The focus on nine-year-old girls mirrors global strategies to prevent cervical cancer and demonstrates a commitment to protecting future generations through proactive immunisation.
